Seattle Angel Conference to win funding for your startup or learn how to angel invest logo

XanthoGenyx (tm) Inc: creating a new immuno-oncology treatment class for Interference Cancer Vaccines(tm). Initial focus is the treatment and diagnostics for Triple-Negative Breast Cancer. Planned exit is via partnering with one or more of twenty identified big pharma oncology companies.

Seattle Angel Conference to win funding for your startup or learn how to angel invest logo
Seattle Angel Conference is a program to learn how to angel invest and for startup companies seeking funding. Seattle Angel Conference is a program of Mossy Ventures.
Sign up for our newsletter
Mossy Ventures angel investing group in Seattle, WA logo
Copyright © 2022 Mossy Ventures
Privacy PolicyWeb Design & SEO by Symphysis
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram